Ascendis Pharma
ASND
ASND
173 hedge funds and large institutions have $9.06B invested in Ascendis Pharma in 2020 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 67 increasing their positions, 53 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
10% more capital invested
Capital invested by funds: $8.25B → $9.06B (+$811M)
1.37% more ownership
Funds ownership: 101.43% → 102.81% (+1.4%)
8% less funds holding in top 10
Funds holding in top 10: 12 → 11 (-1)
Holders
173
Holding in Top 10
11
Calls
$29.7M
Puts
$23.4M
Top Buyers
| 1 | +$149M | |
| 2 | +$25.8M | |
| 3 | +$25.4M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$25M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$23.7M |
Top Sellers
| 1 | -$66.4M | |
| 2 | -$41.7M | |
| 3 | -$29.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$29.7M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$26.5M |